Immunotherapy for Alzheimer's Disease: Rational Basis in Ongoing Clinical Trials

E-ISSN： 1873-4286|17|5|508-520

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.5, 2011-02, pp. : 508-520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ongoing trials in Alzheimer’s disease

By Sramek J.J. Cutler N.R.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 899-915

Informa Healthcare

Access to resources Recommend Favorite

New Developments of Clinical Trial in Immunotherapy for Alzheimer's Disease

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 6, 2015-01 ,pp. : 484-491

Bentham Science Publishers

Access to resources Recommend Favorite

Phytochemicals in Alzheimer Disease: The Development of Clinical Trials

By Quinn Joseph Kaye Jeffrey Montine Thomas Stackman Robert

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 42, Iss. 1, 2004-01 ,pp. : 64-73

Informa Healthcare

Access to resources Recommend Favorite

Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials

By Hassan Sufia Butt Sørensen Jesper Freddie Olsen Barbara Nicola Pedersen Anders Elm

Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 2, 2014-04 ,pp. : 96-104

Informa Healthcare

Access to resources Recommend Favorite

Ongoing clinical trials in systemic hypertension

By Oddou Pascale Mann Jessica

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. : 2031-2037

Informa Healthcare

Access to resources Recommend Favorite